Essential Medicines for Maternal Health: Ensuring Equitable Access for All

Developed by Family Care International on behalf of the Reproductive Health Supplies Coalition (RHSC), this set of 7 policy briefs identifies key challenges and strategies for increasing the availability of three essential maternal health medicines: oxytocin, misoprostol, and magnesium sulfate, which can prevent or treat the leading causes of maternal death (postpartum hemorrhage and pre-eclampsia/eclampsia).

Aimed at national policy makers and program managers, the briefs showcase examples of successful interventions from around the world, highlighting cross-cutting experiences and lessons from reproductive health.

The series includes the following briefs:

  • An overview brief, outlining why maternal health medicines are important, identifying key gaps related to access, and setting out priorities for action
  • Three briefs on the 3 essential maternal health medicines: oxytocin, misoprostol, and magnesium sulfate
  • Three briefs focusing on cross-cutting issues: policy and financing; supply; and demand generation

Available for download in:

English (1.4 MB)

Français (1.6 MB)

Español (1.7 MB)


This publication is only available for download at this time.

© Family Care International, Inc. 2019. All rights reserved. Our Mission | Privacy Policy | Site Map

spam blockers Get Firefox